Evaluation of the impact of GH treatment on primary monocytes isolated from patients experiencing inflammatory conditions, including atherosclerosis, colitis, obesity and even aging might contribute to strengthen the clinical relevance of our observations. This evidence concerns the gene GH1 and obesity disorder.